191 related articles for article (PubMed ID: 9097710)
1. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study.
Kram A; Domagała W
Pol J Pathol; 1996; 47(4):183-7. PubMed ID: 9097710
[TBL] [Abstract][Full Text] [Related]
2. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of proliferating cell nuclear antigen (PCNA) in supraglottic carcinoma.
Liu M; Lawson G; Delos M; Jamart J; Remacle M
Acta Otorhinolaryngol Belg; 1997; 51(3):129-35. PubMed ID: 9350310
[TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical expression of p21WAF1/Cip1 and Proliferating cell nuclear antigen in laryngeal squamous cell carcinomas.
Li X; Izumaru S; Sakamoto K; Miyajima Y; Nakashima T
J Laryngol Otol; 2006 Dec; 120(12):1042-8. PubMed ID: 16995968
[TBL] [Abstract][Full Text] [Related]
6. Correlation of proliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma.
Boran C; Yildiz L; Kandemir B; Karagoz F; Baris S; Aydin O
Neoplasma; 2003; 50(2):139-43. PubMed ID: 12740649
[TBL] [Abstract][Full Text] [Related]
7. Expression of PCNA and bcl-2 in basaloid squamous cell carcinoma of the larynx: a controlled study.
Deniz K; Yüce I; Cağli S; Okten T; Güney E
Ear Nose Throat J; 2008 Aug; 87(8):469-73. PubMed ID: 18712697
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
9. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
Franchi A; Gallo O; Boddi V; Santucci M
Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
[TBL] [Abstract][Full Text] [Related]
10. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
Serio G
Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
12. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
[TBL] [Abstract][Full Text] [Related]
14. [The proliferative activity of laryngeal carcinoma and its relationship to histological malignancy and prognosis].
Zhang Q; Li Y; Liu J
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(5):305-7. PubMed ID: 8762515
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
Gorczyca W; Kram A; Tuziak T; Darzynkiewicz Z; Melamed MR
Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathological correlates of the proliferative activity in squamous cell laryngeal carcinoma.
Bayazit Y; Bakir K; Ucak R; Mumbuc S; Ozer E; Kanlikama M
Rev Laryngol Otol Rhinol (Bord); 2002; 123(1):43-6. PubMed ID: 12201000
[TBL] [Abstract][Full Text] [Related]
17. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
Zhou G; Lin D; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
[TBL] [Abstract][Full Text] [Related]
18. Correlation of proliferating cell nuclear antigen expression with the clinical and biological characteristics and prognosis of hypopharyngeal carcinoma.
Yao LS; Li XP; Li Q; Zhang JH
Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):448-50. PubMed ID: 12390713
[TBL] [Abstract][Full Text] [Related]
19. [Expression of proliferating cell nuclear antigen in superficial bladder cancer--application to paraffin-embedded tissue sections].
Wada T; Shimabukuro T; Kurisu H; Shameem IA; Yoshihiro S; Matsuyama H; Naito K; Hashimoto O; Tanaka K
Hinyokika Kiyo; 1993 Apr; 39(4):313-9. PubMed ID: 8099249
[TBL] [Abstract][Full Text] [Related]
20. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
